Nouscom

Basel biotech developing a cancer-interception vaccine aimed at preventing cancer in people with Lynch syndrome.

View on the globe

$135MEquity raised in 2025–20262025 — · 2026 $135M · 1 equity round
$135MEquity raised, all time1 equity round sourced so far
—Latest valuationnot disclosed

Rounds over time log-scaled amounts

Funding history: 1 round from 19 Oct 2026 to 19 Oct 2026, $135M equity disclosed. Earlier rounds exist but are not sourced.19 Oct 2026: Series D, $135M$10M$30M$100M$300M$1BEarlier rounds exist but are not sourced yet← earlier rounds not sourcedest. 2015Q2Q3Q42027Q2Q3Equity round19 Oct 2026 · Series D · $135M · led by M Ventures, Revelation PartnersSeries D · $135M
Funding history: 1 round from 19 Oct 2026 to 19 Oct 2026, $135M equity disclosed. Earlier rounds exist but are not sourced.19 Oct 2026: Series D, $135M$10M$30M$100M$300M$1BEarlier rounds exist but are not sourced yetearlier rounds not sourced’15Q2Q3Q42027Q2Q3Equity round19 Oct 2026 · Series D · $135M · led by M Ventures, Revelation Partners$135M

Funding history 1 round · 1 source

Earlier rounds not yet sourced. Nouscom was founded in 2015 and raised before 19 Oct 2026; only the rounds below are sourced so far, so its all-time equity total understates its history.

  1. Series D
    Amount$135MEUR 120M
    Post-money—
    ✓ Confirmed
    Lead
    M Ventures, Revelation Partners
    Also
    Angelini Industries, European Investment Bank, Neva SGR
    Note
    Company news page (dated 10/19/2026): "Nouscom Raises €120 Million ($135 Million) in Oversubscribed Series D Financing"; leads M Ventures and Revelation Partners; named participants Angelini Industries, European Investment Bank, Neva SGR. Page truncates the list after "participation", so other participants may exist. Founded 2015 per company boilerplate. "BASEL" dateline is from a company release (CTO appointment) on the same page. Valuation not stated. GlobeNewswire release is 403 from this environment and not opened.
    Sources
  2. Earlier rounds not yet sourced

Investors 5

  • M Ventures1
  • Revelation Partners1
  • Angelini Industries
  • European Investment Bank
  • Neva SGR

Highlighted investors led at least one equity round; the number is equity rounds taken part in.

Related companies shared investors

Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. Nouscom and its logo are trademarks of their owners, used here for identification only.